Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease.

Cucchetti A, Vivarelli M, Heaton ND, Phillips S, Piscaglia F, Bolondi L, La Barba G, Foxton MR, Rela M, O'Grady J, Pinna AD.

Gut. 2007 Feb;56(2):253-8. Epub 2006 Jun 29.

2.

Predicting mortality in patients with cirrhosis of liver with application of neural network technology.

Banerjee R, Das A, Ghoshal UC, Sinha M.

J Gastroenterol Hepatol. 2003 Sep;18(9):1054-60.

PMID:
12911662
3.

MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil.

Marroni CP, de Mello Brandão AB, Hennigen AW, Marroni C, Zanotelli ML, Cantisani G, Fuchs SC; Liver Transplantation Group.

Clin Transplant. 2012 Jul-Aug;26(4):E395-401. doi: 10.1111/j.1399-0012.2012.01688.x.

PMID:
22882694
4.

Serum sodium predicts mortality in patients listed for liver transplantation.

Biggins SW, Rodriguez HJ, Bacchetti P, Bass NM, Roberts JP, Terrault NA.

Hepatology. 2005 Jan;41(1):32-9.

PMID:
15690479
5.

Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.

Lv XH, Liu HB, Wang Y, Wang BY, Song M, Sun MJ.

J Gastroenterol Hepatol. 2009 Sep;24(9):1547-53. doi: 10.1111/j.1440-1746.2009.05913.x. Epub 2009 Aug 3.

PMID:
19686416
6.

Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation.

Gotthardt D, Weiss KH, Baumgärtner M, Zahn A, Stremmel W, Schmidt J, Bruckner T, Sauer P.

BMC Gastroenterol. 2009 Sep 25;9:72. doi: 10.1186/1471-230X-9-72.

7.

[The prognostic value of end-stage liver disease model in liver cirrhosis].

Zhang JY, Zhang FK, Wang BE, Jia JD, Zhang ST.

Zhonghua Nei Ke Za Zhi. 2005 Nov;44(11):822-4. Chinese.

PMID:
16316560
8.

MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation.

Londoño MC, Cárdenas A, Guevara M, Quintó L, de Las Heras D, Navasa M, Rimola A, Garcia-Valdecasas JC, Arroyo V, Ginès P.

Gut. 2007 Sep;56(9):1283-90. Epub 2007 Apr 23.

9.

Model for end-stage liver disease (MELD) and allocation of donor livers.

Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, Kremers W, Lake J, Howard T, Merion RM, Wolfe RA, Krom R; United Network for Organ Sharing Liver Disease Severity Score Committee.

Gastroenterology. 2003 Jan;124(1):91-6.

PMID:
12512033
10.

Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.

Yamashiki N, Sugawara Y, Tamura S, Kaneko J, Nojiri K, Aoki T, Sakamoto Y, Hasegawa K, Koike K, Kokudo N.

Transplant Proc. 2012 Mar;44(2):389-92. doi: 10.1016/j.transproceed.2012.01.037.

PMID:
22410024
11.

A model to predict 3-month mortality risk of acute-on-chronic hepatitis B liver failure using artificial neural network.

Zheng MH, Shi KQ, Lin XF, Xiao DD, Chen LL, Liu WY, Fan YC, Chen YP.

J Viral Hepat. 2013 Apr;20(4):248-55. doi: 10.1111/j.1365-2893.2012.01647.x. Epub 2012 Aug 3.

PMID:
23490369
12.

Different models in predicting the short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure.

Yang WB, Chen EQ, Bi HX, Bai L, Chen XB, Feng P, Tang H.

Ann Hepatol. 2012 May-Jun;11(3):311-9.

13.

Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: Which is the winner?

Biselli M, Gitto S, Gramenzi A, Di Donato R, Brodosi L, Ravaioli M, Grazi GL, Pinna AD, Andreone P, Bernardi M.

Liver Transpl. 2010 Aug;16(8):964-73. doi: 10.1002/lt.22093.

14.

Is the model of end-stage liver disease (MELD) valid in Israel? A critical analysis of liver transplant waiting list mortality.

Ben-Haim M, Carmiel M, Katz P, Shabtai E, Oren R, Nakache R.

Isr Med Assoc J. 2006 Sep;8(9):605-9.

15.

Comparison of hepatic venous pressure gradient and two models of end-stage liver disease for predicting the survival in patients with decompensated liver cirrhosis.

Suk KT, Kim CH, Park SH, Sung HT, Choi JY, Han KH, Hong SH, Kim DY, Yoon JH, Kim YS, Baik GH, Kim JB, Kim DJ.

J Clin Gastroenterol. 2012 Nov-Dec;46(10):880-6. doi: 10.1097/MCG.0b013e31825f2622.

PMID:
22810110
16.

Evaluation of indocyanine green clearance and model for end-stage liver disease for estimation of short-term prognosis in decompensated cirrhosis.

Stauber RE, Wagner D, Stadlbauer V, Palma S, Gurakuqi G, Kniepeiss D, Iberer F, Smolle KH, Haas J, Trauner M.

Liver Int. 2009 Nov;29(10):1516-20. doi: 10.1111/j.1478-3231.2009.02104.x. Epub 2009 Sep 3.

PMID:
19732329
17.

[Prognostic value of the model for end-stage liver disease combined with serum sodium levels in patients with decompensated cirrhosis].

Li JY, Deng Q, Wang Y, Xu MY, Lu LG.

Zhonghua Gan Zang Bing Za Zhi. 2012 Dec;20(12):896-901. doi: 10.3760/cma.j.issn.1007-3418.2012.12.005. Chinese.

PMID:
23522249
18.

Liver dysfunction by model for end-stage liver disease score improves mortality prediction in injured patients with cirrhosis.

Corneille MG, Nicholson S, Richa J, Son C, Michalek J, Wolf SE, Stewart R.

J Trauma. 2011 Jul;71(1):6-11. doi: 10.1097/TA.0b013e31822311c5.

PMID:
21818010
19.

Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis.

Huo TI, Lin HC, Huo SC, Lee PC, Wu JC, Lee FY, Hou MC, Lee SD.

Liver Transpl. 2008 Jun;14(6):837-44. doi: 10.1002/lt.21439.

20.

Model for End-Stage Liver Disease score for predicting outcome in critically ill medical patients with liver cirrhosis.

Cavallazzi R, Awe OO, Vasu TS, Hirani A, Vaid U, Leiby BE, Kraft WK, Kane GC.

J Crit Care. 2012 Aug;27(4):424.e1-6. doi: 10.1016/j.jcrc.2011.11.014. Epub 2012 Jan 9.

PMID:
22227088

Supplemental Content

Support Center